A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD)

Measuring the severity and progression of facioscapulohumeral muscular dystrophy (FSHD) is particularly challenging because muscle weakness progresses over long periods of time and can be sporadic. Biomarkers are essential for measuring disease burden and testing treatment strategies. We utilized th...

Descripción completa

Detalles Bibliográficos
Autores principales: Petek, Lisa M., Rickard, Amanda M., Budech, Christopher, Poliachik, Sandra L., Shaw, Dennis, Ferguson, Mark R., Tawil, Rabi, Friedman, Seth D., Miller, Daniel G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912392/
https://www.ncbi.nlm.nih.gov/pubmed/27185459
http://dx.doi.org/10.1016/j.nmd.2016.04.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912392/
https://www.ncbi.nlm.nih.gov/pubmed/27185459
http://dx.doi.org/10.1016/j.nmd.2016.04.012

Ejemplares similares